Verastem (VSTM) Assets Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.72% |
| Dec 31, 2025 | 9.81% |
| Sep 30, 2025 | -4.08% |
| Jun 30, 2025 | -0.23% |
| Mar 31, 2025 | -8.75% |
| Dec 31, 2024 | -6.88% |
| Sep 30, 2024 | -8.08% |
| Jun 30, 2024 | -13.51% |
| Mar 31, 2024 | -12.68% |
| Dec 31, 2023 | -11.59% |
| Sep 30, 2023 | -0.78% |
| Jun 30, 2023 | 2.09% |
| Mar 31, 2023 | 12.06% |
| Dec 31, 2022 | 1.14% |
| Sep 30, 2022 | 11.96% |
| Jun 30, 2022 | 10.18% |
| Mar 31, 2022 | 8.78% |
| Dec 31, 2021 | 5.38% |
| Sep 30, 2021 | 4.67% |
| Jun 30, 2021 | 5.36% |
| Mar 31, 2021 | 5.95% |
| Dec 31, 2020 | 6.42% |
| Sep 30, 2020 | 11.98% |
| Jun 30, 2020 | 7.91% |
| Mar 31, 2020 | 7.95% |
| Dec 31, 2019 | 8.01% |
| Sep 30, 2019 | 14.50% |
| Jun 30, 2019 | 15.28% |
| Mar 31, 2019 | 16.03% |
| Dec 31, 2018 | 17.22% |
| Sep 30, 2018 | 6.70% |
| Jun 30, 2018 | 16.68% |
| Mar 31, 2018 | -4.53% |
| Dec 31, 2017 | -0.68% |
| Sep 30, 2017 | -8.57% |
| Jun 30, 2017 | -10.16% |
| Mar 31, 2017 | -7.19% |
| Dec 31, 2016 | 7.21% |